Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Alzheimers Dement. 2018 Jan 4;14(6):797–810. doi: 10.1016/j.jalz.2017.11.014

Table 1.

ADNI Demographic info

Disease Stage Group Size (Age) M (Age) F (Age) MMSE
Control 232 (75.14 ± 6.92) 110 (76.37 ± 7.00) 122 (74.03 ± 6.68) 28.79 ± 1.14
AD 153 (75.06 ± 8.07) 87 (76.19 ± 7.90) 66 (73.57 ± 8.12) 20.92 ± 4.08
EMCI 327 (71.85 ± 7.46) 179 (72.47 ± 7.20) 148 (71.09 ± 7.73) 27.96 ± 1.71
MCI 2 (85.45 ± 6.01) 1 (89.7 ± 0) 1 (81.2 ± 0) 16 ± 12.73
LMCI 201 (73.59 ± 7.77) 113 (75 ± 7.52) 87 (71.66 ± 7.71) 26.06 ± 3.09
*

None of the ADNI patients have confirmed pathology. Patients who did not pass Freesurfer analysis were not included in the study. ADNI demographic info can be found at: http://adni.loni.usc.edu/wp-content/uploads/2012/08/ADNI_Enroll_Demographics.pdf